Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Nuclear Medicine

Free Subscription 25.05.2026 1 AJNR Am J Neuroradiol 6 Ann Nucl Med 1 Circ Cardiovasc Imaging 13 Clin Nucl Med 4 J Nucl Cardiol 7 J Nucl Med 3 Nucl Med Commun 3 Nuklearmedizin 2 Phys Med Biol 1 Proc Natl Acad Sci U S A 2 Semin Nucl Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. JASWAL S, Ghaderi Yazdi B, Khalafi M, Ozoria S, et al
   In Vivo [18F]MK6240 PET Reveals Atypical Patterns of Early Tau Deposition and Evidence for Primary Age-Related Tauopathy in Community-Residing Adults.
   AJNR Am J Neuroradiol. 2026 May 18:ajnr.A9420. doi: 10.3174/ajnr.A9420.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

2. ERDOGAN M, Korkmaz H, Avci M, Ozdemir Z, et al
   Early clinical experience with (6)(8)Ga-Trivehexin PET/CT in parathyroid adenomas: a proof-of- concept imaging study.
   Ann Nucl Med. 2026 May 22. doi: 10.1007/s12149-026-02232.
   PubMed         Abstract available
   
   
3. SOYDAS-TURAN B, Volkan-Salanci B, Aydin B, Kiratli P, et al
   18 F-FDG PET/CT Derived Volumetric Parameters Can Predict Outcome in Pediatric Ewing Sarcoma.
   Ann Nucl Med. 2026 May 21. doi: 10.1007/s12149-026-02229.
   PubMed         Abstract available
   
   
4. LIN YC, Chang CC, Yeh TJ, Hsieh TY, et al
   Baseline FDG PET/CT SUVmax predicts POD24 and progression-free survival in newly diagnosed follicular lymphoma.
   Ann Nucl Med. 2026 May 20. doi: 10.1007/s12149-026-02230.
   PubMed         Abstract available
   
   
5. USMANI S, Hashmi SF, Jain A, Al Saifi S, et al
   Integration of (6)(8)Ga-DOTA-TOC PET/CT into radiotherapy planning for intracranial meningiomas: A precision-imaging approach to tumor delineation.
   Ann Nucl Med. 2026 May 19. doi: 10.1007/s12149-026-02226.
   PubMed         Abstract available
   
   
6. YAMAKUNI R, Seino S, Yamaki A, Shima A, et al
   Whole-brain histogram analysis and top 20% gray and white matter ratio of amyloid positron emission tomography: A comparison with the centiloid scale.
   Ann Nucl Med. 2026 May 18. doi: 10.1007/s12149-026-02218.
   PubMed         Abstract available
   
   
7. CHIARAVALLOTI A, Egidi M, D'Agostini A, Filippi L, et al
   Semiquantitative SSTR PET metrics show molecular-morphologic discordance after 177Lu-DOTATATE in gastroenteropancreatic neuroendocrine neoplasms: an exploratory paired target-lesion analysis.
   Ann Nucl Med. 2026 May 18. doi: 10.1007/s12149-026-02231.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

8. GROSCHEL J, Heidecker B, Bhoyroo Y, Spethmann S, et al
   How to Image Myocarditis.
   Circ Cardiovasc Imaging. 2026;19:e018547.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

9. OKSUZOGLU K, Perktas L, Onner H, Yilmaz F, et al
   Hepatic Perfusion-Related Pseudolesion Mimicking Metastasis on 68Ga-PSMA PET/CT.
   Clin Nucl Med. 2026 May 5. doi: 10.1097/RLU.0000000000006520.
   PubMed         Abstract available
   
   
10. CHEN X, Zhang Y, Wu C, Fu Z, et al
    18F-FDG PET/CT in a Patient With Anal Angiosarcoma.
    Clin Nucl Med. 2026 May 11. doi: 10.1097/RLU.0000000000006429.
    PubMed         Abstract available
    
    
11. KERROU K, Gligorov J
    Functional Estrogen Receptor Assessment: Insights From Discordant 18F-FES PET/CT and ER Immunohistochemistry.
    Clin Nucl Med. 2026 May 8. doi: 10.1097/RLU.0000000000006515.
    PubMed        
    
    
12. EL YAAGOUBI Y, Prunier-Aesch C, Wargnier O, Philippe L, et al
    Iliotibial Band Syndrome Detected by Bloodpool SPECT/CT Using New 3D-Ring CZT System.
    Clin Nucl Med. 2026 May 11. doi: 10.1097/RLU.0000000000006477.
    PubMed         Abstract available
    
    
13. CHARBEL C, Woo S, Becker AS, Bruzzese A, et al
    Focal Small Bowel FDG Uptake in Cancer Patients Undergoing PET/CT: Prevalence and Etiology.
    Clin Nucl Med. 2026 May 5. doi: 10.1097/RLU.0000000000006480.
    PubMed         Abstract available
    
    
14. DAI Y, Pan Z, Li D, Dong A, et al
    FDG PET/CT in a Case of Primary Bilateral Adrenal Dedifferentiated Liposarcoma.
    Clin Nucl Med. 2026 May 11. doi: 10.1097/RLU.0000000000006534.
    PubMed         Abstract available
    
    
15. HE J, Zhang X, Dong A
    FDG PET/CT in a Case of Post-Hysterectomy Adnexal Torsion.
    Clin Nucl Med. 2026 May 11. doi: 10.1097/RLU.0000000000006522.
    PubMed         Abstract available
    
    
16. TAGGAR M, Shamim SA, Jain R, Yadav SK, et al
    Agonist Trap Unmasked: 68Ga-DOTANOC Fibroid Mimicry Resolved by 68Ga-NODAGA-JR11 Antagonist PET.
    Clin Nucl Med. 2026 May 13. doi: 10.1097/RLU.0000000000006506.
    PubMed         Abstract available
    
    
17. USMANI S, Elshafie O, Jain A, Al Rawahi A, et al
    68Ga-DOTATOC PET/CT in the Evaluation of Carney Triad Spectrum Tumors With an Associated Adrenal Adenoma.
    Clin Nucl Med. 2026 May 12. doi: 10.1097/RLU.0000000000006544.
    PubMed         Abstract available
    
    
18. XIAO Z, Dong A, Zhang F, Zuo C, et al
    Bone Scintigraphy and FDG PET/CT in a Case of Pulmonary NUT Carcinoma With Only Initial Presentation of Bony Metastasis to the Distal Phalanx of the Little Finger Following Traumatic Injury.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006538.
    PubMed         Abstract available
    
    
19. AL RIYAMI K, Jain A, Al Busaidi A, Ismaila A, et al
    Beyond FDG: Serial 68Ga-FAPI PET/CT for Staging and Treatment Response Assessment in Metastatic Pleomorphic Lobular Breast Cancer.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006540.
    PubMed         Abstract available
    
    
20. CHENG J, Yuan H, Su M
    Pleural Metastasis as the Only Presentation of Recurrent Cervical Carcinoma on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006545.
    PubMed         Abstract available
    
    
21. ELAHIFARD H, Samadi MH, Saberifar M, Makhdoumi Y, et al
    Theranostic Application of FAPI in Advanced Laryngeal Squamous Cell Carcinoma: 99mTc-FAPI-46 SPECT/CT Guided 177Lu-FAPI-2286 Therapy.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006505.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

22. TERSALVI G, Tomasoni D, Coderre R, Kourelis TV, et al
    Cardiac amyloidosis: Disease overview and novel pathophysiologic insights.
    J Nucl Cardiol. 2026;59S:102723.
    PubMed         Abstract available
    
    
23. MILLER RJ, Clerc OF, Cuddy SA, Auer B, et al
    Quantitative cardiac amyloid radionuclide imaging.
    J Nucl Cardiol. 2026;59S:102724.
    PubMed         Abstract available
    
    
24. AL BADARIN F, Camilletti J, Benz DC, Better N, et al
    Cardiac amyloid radionuclide imaging: Global perspective and future priorities.
    J Nucl Cardiol. 2026;59S:102725.
    PubMed         Abstract available
    
    
25. WALL JS, Martin EB
    An era of precision: Emerging, research, and adjunct radiotracers for nuclear imaging of cardiac amyloidosis.
    J Nucl Cardiol. 2026;59S:102726.
    PubMed         Abstract available
    
    

    
    J Nucl Med

26. MULUGETA PG, O'Brien SR, Mankoff DA, Sartor O, et al
    A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT.
    J Nucl Med. 2026 May 21:jnumed.125.271508. doi: 10.2967/jnumed.125.271508.
    PubMed        
    
    
27. WANG Y, Wood JL, Thurecht KJ, Yeoh SY, et al
    Assessing Value for Money in Theranostic Nuclear Medicine: A Systematic Review.
    J Nucl Med. 2026 May 21:jnumed.125.271469. doi: 10.2967/jnumed.125.271469.
    PubMed         Abstract available
    
    
28. ARCAY OZTURK A, Liberale G, Deleu AL, Poenaru R, et al
    Preoperative Assessment of Peritoneal Carcinomatosis with [(68)Ga]Ga-FAPI-46 PET/CT: Agreement with Surgicopathologic PCI and Comparison with MRI and [(18)F]FDG PET/CT.
    J Nucl Med. 2026 May 21:jnumed.126.272183. doi: 10.2967/jnumed.126.272183.
    PubMed         Abstract available
    
    
29. SOMMA C, Zimmermann R, Gericke G, Herrmann K, et al
    Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 1.
    J Nucl Med. 2026 May 21:jnumed.125.270855. doi: 10.2967/jnumed.125.270855.
    PubMed         Abstract available
    
    
30. LUCKERATH K, Minguez Gabina P, Eberlein U, Kurth J, et al
    Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor Combinations.
    J Nucl Med. 2026 May 21:jnumed.125.271527. doi: 10.2967/jnumed.125.271527.
    PubMed         Abstract available
    
    
31. SOMMA C, Zimmermann R, Gericke G, Herrmann K, et al
    Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 2.
    J Nucl Med. 2026 May 21:jnumed.125.270945. doi: 10.2967/jnumed.125.270945.
    PubMed         Abstract available
    
    
32. URIBE C, Iravani A, Savir-Baruch B, Jacene H, et al
    Reply: A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT.
    J Nucl Med. 2026 May 21:jnumed.126.272083. doi: 10.2967/jnumed.126.272083.
    PubMed        
    
    

    
    Nucl Med Commun

33. HAROON A, Almuhaideb A, Adeleke S, Endozo R, et al
    From 18F-choline to prostate-specific membrane antigen PET: lessons from early multiparametric kinetic modelling in prostate cancer.
    Nucl Med Commun. 2026 May 19. doi: 10.1097/MNM.0000000000002166.
    PubMed         Abstract available
    
    
34. WANG Y, Duan R
    Evaluating the role of quantitative dual lumbar vertebral radioactive counts ratio using 99m-technetium-labeled methylene diphosphonate single-photon emission computed tomography/computed tomography in the assessment of osteoporosis.
    Nucl Med Commun. 2026 May 22. doi: 10.1097/MNM.0000000000002182.
    PubMed         Abstract available
    
    
35. JIA YN, Wu Q, Liu PH
    Evolutionary landscape and collaborative networks of global theranostic research in nuclear medicine: a visual bibliometric analysis.
    Nucl Med Commun. 2026 May 22. doi: 10.1097/MNM.0000000000002183.
    PubMed         Abstract available
    
    

    
    Nuklearmedizin

36. BARTHEL H, Brendel M, Albert N, Boecker H, et al
    Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0.
    Nuklearmedizin. 2026;65:223-235.
    PubMed         Abstract available
    
    
37. TATOGLU MT, Okten IN, Ibisoglu E, Soylemez Akkurt T, et al
    Baseline FDG PET/CT-Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer.
    Nuklearmedizin. 2026;65:207-216.
    PubMed         Abstract available
    
    
38. SIEGMUND SC, Serfling SE, Higuchi T, Buck A, et al
    Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck.
    Nuklearmedizin. 2026;65:217-222.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

39. SHIM HS, Cho MJ, He W, Lee MS, et al
    Influence of scintillation light confinement on depth-of-interaction measurement performance in a single-Ended readout PET detector.
    Phys Med Biol. 2026 May 15. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    
40. KUTOS JC, von Kietzell A, McGowan I, Bertoglio D, et al
    Image-derived input functions for [(18)F]LW223 and [(18)F]SynVesT-1 PET in the rodent determined using an autoencoder (IDIF-AE).
    Phys Med Biol. 2026 May 15. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

41. KALITA M, Kuo RC, Straniero V, Reyes ST, et al
    Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.
    Proc Natl Acad Sci U S A. 2026;123:e2536372123.
    PubMed         Abstract available
    
    

    
    Semin Nucl Med

42. WOPPERER SB, Kronzer E, Ivare J, Taheri M, et al
    FDG PET for cardiac sarcoidosis: Protocol optimization, quantification, pitfalls, and multimodality imaging integration.
    Semin Nucl Med. 2026 May 21:S0001-2998(26)00093.
    PubMed         Abstract available
    
    
43. HAMMOUD DA
    Imaging of immunocompromised patients: focus on fungal-specific PET tracers.
    Semin Nucl Med. 2026 May 18:S0001-2998(26)00095.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum